SRRM1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the JAK/STAT signaling pathway
Authors:
- 12 October 2022
- journal article
- research article
- Published by Elsevier in Tissue and Cell
- Vol. 79, 101954
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- JAK2-STAT3 Blockade by AG490 Suppresses Autoimmune Arthritis in Mice via Reciprocal Regulation of Regulatory T Cells and Th17 CellsThe Journal of Immunology, 2014
- Tyrosine Kinase Inhibitor Tyrphostin AG490 Retards Chronic Joint Inflammation in MiceInflammation, 2014
- A day in the life of the spliceosomeNature Reviews Molecular Cell Biology, 2014
- Regulation of Telomerase Alternative Splicing: A Target for ChemotherapyCell Reports, 2013
- gp130 at the nexus of inflammation, autoimmunity, and cancerJournal of Leukocyte Biology, 2010
- Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cellsBiochemical and Biophysical Research Communications, 2007
- Regulation of CD44 Alternative Splicing by SRm160 and Its Potential Role in Tumor Cell InvasionMolecular and Cellular Biology, 2006
- An Evolutionarily Conserved Role for SRm160 in 3′-End Processing That Functions Independently of Exon Junction Complex FormationJournal of Biological Chemistry, 2003
- The spatial targeting and nuclear matrix binding domains of SRm160Proceedings of the National Academy of Sciences, 2003
- SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activityNature Genetics, 2001